NRX Pharmaceuticals, Inc. Warrant
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NRXPW Company Description
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NRXPW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NRXPW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NRXPW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NRXPW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of NRXPW in WallStreetBets Daily Discussion
NRXPW News
Recent insights relating to NRXPW
CNBC Recommendations
Recent picks made for NRXPW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NRXPW
Corporate Flights
Flights by private jets registered to NRXPW
Our Analysis